The presence of higher serum CRP levels and the tissue location of CRP in patients with AS have raised the important question of whether medical therapies with agents such as statins and ACE inhibitors, which have already been shown to delay the progression of atherosclerosis may also affect the progression of AS. This evidence concerns the gene ACE and aortic stenosis.